All Updates

All Updates

icon
Filter
Funding
CubicFarm Systems announces prices and terms for USD 10 million overnight marketed offering
Vertical Farming
May 27, 2022
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Partnerships
Funding
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Vertical Farming

Vertical Farming

May 27, 2022

CubicFarm Systems announces prices and terms for USD 10 million overnight marketed offering

Funding

  • CubicFarm Systems, a Canadian vertical farming technology solutions provider, has announced the price and terms of the company’s overnight marketed offering of unsecured convertible debenture units and common shares. The offering will be carried out on a best efforts agency basis led by joint bookrunners Raymond James Ltd and Canaccord Genuity Corp.

  •  The company will offer debenture units and common shares at a price of USD 1,000 per debenture unit and USD 0.55 per common share to raise a total of USD 10 million. Each debenture unit will include a 5-year 8% unsecured convertible debenture with 400 common share purchase warrants. The holder will be entitled to exercise each warrant for one common share of the company until June 2, 2025 at a price of USD 0.71. The debentures can be converted into common shares of the company at a fixed price of USD 0.68 per share. Holders can exercise this option at any time before the maturity date and the company’s share redemption date.

  • Holders will also have an over-allotment option to sell an additional 15% of debenture units and shares, which can be exercised at any time within 30 days following the closing date of the offering.

  • The funds will be used to support working capital, R&D, and business development. The offering is expected to close on June 2, 2022 subject to the approval of the Toronto Stock Exchange (TSX) and other regulatory requirements.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.